Kamran N - Search Results

1

Current state and future prospects of immunotherapy for glioma.

Kamran N, Alghamri MS, Nunez FJ, Shah D, Asad AS, Candolfi M, Altshuler D, Lowenstein PR, Castro MG. Kamran N, et al. Immunotherapy. 2018 Feb 1;10(4):317-339. doi: 10.2217/imt-2017-0122. Immunotherapy. 2018. PMID: 29421984 Free PMC article. Review.

2

Adenoviral vector-mediated gene therapy for gliomas: coming of age.

Castro MG, Candolfi M, Wilson TJ, Calinescu A, Paran C, Kamran N, Koschmann C, Moreno-Ayala MA, Assi H, Lowenstein PR. Castro MG, et al. Among authors: kamran n. Expert Opin Biol Ther. 2014 Sep;14(9):1241-57. doi: 10.1517/14712598.2014.915307. Epub 2014 Apr 29. Expert Opin Biol Ther. 2014. PMID: 24773178 Free PMC article. Review.

3

Blockade of mTOR signaling via rapamycin combined with immunotherapy augments antiglioma cytotoxic and memory T-cell functions.

Mineharu Y, Kamran N, Lowenstein PR, Castro MG. Mineharu Y, et al. Among authors: kamran n. Mol Cancer Ther. 2014 Dec;13(12):3024-36. doi: 10.1158/1535-7163.MCT-14-0400. Epub 2014 Sep 25. Mol Cancer Ther. 2014. PMID: 25256739 Free PMC article.

4

Overview of current immunotherapeutic strategies for glioma.

Calinescu AA, Kamran N, Baker G, Mineharu Y, Lowenstein PR, Castro MG. Calinescu AA, et al. Among authors: kamran n. Immunotherapy. 2015;7(10):1073-104. doi: 10.2217/imt.15.75. Immunotherapy. 2015. PMID: 26598957 Free PMC article. Review.

5

Recent advances and future of immunotherapy for glioblastoma.

Kamran N, Calinescu A, Candolfi M, Chandran M, Mineharu Y, Asad AS, Koschmann C, Nunez FJ, Lowenstein PR, Castro MG. Kamran N, et al. Expert Opin Biol Ther. 2016 Oct;16(10):1245-64. doi: 10.1080/14712598.2016.1212012. Epub 2016 Jul 27. Expert Opin Biol Ther. 2016. PMID: 27411023 Free PMC article. Review.

6

Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy.

Kamran N, Chandran M, Lowenstein PR, Castro MG. Kamran N, et al. Clin Immunol. 2018 Apr;189:34-42. doi: 10.1016/j.clim.2016.10.008. Epub 2016 Oct 21. Clin Immunol. 2018. PMID: 27777083 Free PMC article. Review.

7

Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.

Kamran N, Kadiyala P, Saxena M, Candolfi M, Li Y, Moreno-Ayala MA, Raja N, Shah D, Lowenstein PR, Castro MG. Kamran N, et al. Mol Ther. 2017 Jan 4;25(1):232-248. doi: 10.1016/j.ymthe.2016.10.003. Epub 2017 Jan 4. Mol Ther. 2017. PMID: 28129117 Free PMC article.

8

Functional characterization of tumor antigen-specific T-cells isolated from the tumor microenvironment of sleeping beauty induced murine glioma models.

Alghamri MS, Núñez FJ, Kamran N, Carney S, Altshuler D, Lowenstein PR, Castro MG. Alghamri MS, et al. Among authors: kamran n. Methods Enzymol. 2020;631:91-106. doi: 10.1016/bs.mie.2019.05.032. Epub 2019 Jun 8. Methods Enzymol. 2020. PMID: 31948569 Free PMC article.

9

Functional assay to assess T-cell inhibitory properties of myeloid derived suppressor cells (MDSCs) isolated from the tumor microenvironment of murine glioma models.

Alghamri MS, Kamran N, Kadiyala P, Lowenstein PR, Castro MG. Alghamri MS, et al. Among authors: kamran n. Methods Enzymol. 2020;632:215-228. doi: 10.1016/bs.mie.2019.05.047. Epub 2019 Jun 18. Methods Enzymol. 2020. PMID: 32000897 Free PMC article.

10

Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models.

Candolfi M, Yagiz K, Wibowo M, Ahlzadeh GE, Puntel M, Ghiasi H, Kamran N, Paran C, Lowenstein PR, Castro MG. Candolfi M, et al. Among authors: kamran n. Clin Cancer Res. 2014 Mar 15;20(6):1555-1565. doi: 10.1158/1078-0432.CCR-13-2140. Epub 2014 Feb 5. Clin Cancer Res. 2014. PMID: 24501391 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page